Unique gene that staves off heart disease identified

Image
Press Trust of India London
Last Updated : May 28 2017 | 4:48 PM IST
Scientists have identified a unique gene variant in people living in isolated Greek villages that protects them from heart diseases despite enjoying a high-fat diet.
The variant, rs145556679*, is associated with lower levels of both 'bad' natural fats and 'bad' cholesterol, the factors that lower the risk of cardiovascular disease, said researchers from Wellcome Trust Sanger Institute in the UK.
The cardioprotective variant was found in Mylopotamos, northern Crete where the population is isolated and live a long life despite having a diet rich in animal fat.
Researchers made a genetic portrait of the population by sequencing the entire genome of 250 individuals to get an in- depth view.
The team then used the results to give a more detailed view of about 3,200 people for whom previous genetic information was known.
Scientists discovered a new genetic variant that was not previously known to have cardioprotective qualities.
The cardioprotective variant may be almost unique to the Mylopotamos population, researchers said as the genome sequencing results of a few thousand Europeans only revealed one copy of this variant in a single individual in Tuscany, Italy.
Researchers also found a separate variant in the same gene to be associated with lower levels of triglycerides in the Amish founder population in the US.
"We were able to identify those genetic variants that are at a higher frequency compared to cosmopolitan populations and this in turn increases our power to detect if these variants are disease causing," said Lorraine Southam from Wellcome Trust Sanger Institute.
"With isolated populations, we can get a unique view into rare genetic variants that play important roles in complex human diseases," Southam said.
Researchers also studied an isolated population from mountainous villages in the Pomak region of northern Greece.
They looked at the genetics of about 1700 people in the population and discovered four separate genetic variants that affect diastolic blood pressure, fasting glucose levels, white blood cell count and haemoglobin levels.
The study was published in the journal Nature Communications.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 28 2017 | 4:48 PM IST

Next Story